Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG) | 200 |
Total Visits per Month
| November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|
| INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG) | 21 | 11 | 11 | 7 | 9 | 14 | 11 |
File Downloads
| Views | |
|---|---|
| hdl_138674.pdf | 53 |
Top Country Views
| Views | |
|---|---|
| Australia | 75 |
| United States | 66 |
| Vietnam | 9 |
| Hong Kong SAR China | 7 |
| Singapore | 6 |
| Argentina | 5 |
| Belgium | 5 |
| China | 5 |
| Ireland | 5 |
| India | 2 |
Top City Views
| Views | |
|---|---|
| New York | 18 |
| Hanoi | 9 |
| Ashburn | 7 |
| Central | 7 |
| Boardman | 6 |
| Brussels | 5 |
| Sydney | 5 |
| Dublin | 4 |
| Sandston | 3 |
| Melbourne | 2 |